Other studies have indicated an additional potential role in MDM2 expression and cancer risk for an Indel (insertion/deletion) polymorphism located at position -2026_-2025 in the constitutive promoter P1 region of the MDM2 gene [15,27,28,29]. This evidence concerns the gene MDM2 and cancer.